The total transaction amounted to $87,500. Post-transaction, Mr. Valentine owned 74,785 shares valued at around $4.6 million. At the end of July, the company reported $190.7 million for the second quarter, up from the consensus estimate of $177.5 million.
Brean Capital upgraded NuVasive shares from “hold” to “buy” on Sept. 30. The company’s stock opened at $35.29 today with a market cap at $1.68 billion. The 52-week high is $39.89 and low is $24.05.
More articles on orthopedic devices:
Nevro files IPO—6 things to know
Amedica appoints Eric Stookey to board of directors
PODs under attack—5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
